Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Sanofi

Why Olympian Jordan Chiles is raising awareness of type 1 diabetes

“If I had type 1 diabetes as an athlete, I don't think I could be as strong as how my aunt is right now," Chiles says about her inspiration for advocacy work.

Fortune

3 Pharma Stocks to Buy as California Sounds the Alarm on Bird Flu Cases

The bird flu crisis is creating investment opportunities in the pharmaceutical sector, with Sanofi, GSK, and CSL Limited emerging as top picks.

Barchart

Teva Catapults 26%, Hitting A Six-Year High, After Scoring A Win With Sanofi-Tied Drug

Teva stock catapulted Tuesday after its inflammatory bowel disease treatment showed "best-in-class potential" in a Phase 2 study.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Sanofi exec says remote work takes away employee 'serendipity'

“I think we were contrarians,” Sanofi’s chief digital officer, Emmanuel Frenehard, told Fortune. “I think the contrarians are becoming the norm.”

Fortune

Sanofi CEO Paul Hudson takes inspiration from 'Fight Club' to get his team hooked on AI

Hudson says many CEOs are scared of AI, comparing it to The Terminator’s John Connor traveling back in time to stop the rise of the machines.

Fortune

Epilepsy medication affected Sophie’s pregnancies. Should Australia adopt tougher guidelines?

Exclusive: FoI documents show Advisory Committee on Medicines considered tightening prescribing requirements for sodium valproate – but chose not to

The Guardian - AU

Here’s what the top business leaders are saying about AI: 'You need to be prepared for anything'

CEOs at Fortune Global Forum unpack how AI will impact the labor market and corporate America.

Fortune

Read news from The Economist, FT, and more,
with one subscription

CEO of pharma giant Sanofi says businesses should stop 'AI washing'

Some companies are overselling AI without thinking through the risks, according to Paul Hudson

Fortune

Bird flu has been detected in a pig in the US. Why does that matter?

The United States Department of Agriculture last week reported that a pig on a backyard farm in Oregon was infected with bird flu.

The Conversation

Regeneron Takes A Ghastly Turn As High-Dose Eylea Lags And Biosimilars Loom

Regeneron stock toppled Thursday after the biotech giant reported lighter-than-expected sales of its new eye disease drug.

Investors Business Daily

Sanofi Eyes Breakout After Pharma Titan Rides Vaccine Sales To Quarterly Beat

Sanofi stock rose Friday after beating third-quarter sales expectations on the back of its vaccine sales.

Investors Business Daily

Sanofi confirms €16 billion sale of painkiller Doliprane to US investors

French pharamceutical giant Sanofi has confirmed plans to sell a controlling stake in its over-the-counter unit to a US investment fund, after employment and investment guarantees relieved political controversy.

Radio France Internationale

France Bristles At Painkiller Maker's Sale To US Fund

French drugmaker Sanofi's Monday confirmation that it plans to sell a controlling stake in its over-the-counter unit to a US investment fund sparked a new political backlash, stoked by fears the deal marks a loss of sovereignty over key medications.

International Business Times

France warns US buyer of Sanofi division of penalties for shifting production abroad

Private equity firm CD&R revealed to be in exclusive talks to buy 50% stake in consumer healthcare arm Opella

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

International Business Times

Sanofi Pursues Sale Of Painkiller After Political Controversy

Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, after employment and investment guarantees relieved political controversy.

The Guardian - UK

‘The UK is at the back of the race of turtles’: Sanofi’s boss on the need to develop new medicines

Paul Hudson, the Briton in charge of the French drug firm, is a big believer in the potential of AI to transform healthcare

Radio France Internationale

France could block sale of 'best-selling' drug if production doesn't stay local

France’s Economy Minister has warned that the government could block the sale of a subsidiary of the French pharmaceutical company Sanofi to a US private equity firm if it cannot guarantee that its production of paracetamol, under the name Doliprane, remains in France.

International Business Times

Painkiller Sale Plan To US Gives France Major Headache

The planned sale of France's best-selling medical drug to US investors has caused the government a splitting headache after an outcry against the project from politicians on all sides.

Get all your
news in one place.

100’s of premium titles.
One news app.

France 24

Pharmaceutical giant Sanofi looks to sell consumer health unit, sparks political uproar

France's Economy and Industry ministers, Antoine Armand and Marc Ferracci, are heading to Lisieux this Monday to visit the production sites of popular headache reliever Doliprane. The visit takes place after the maker of the pill, French pharma group Sanofi, said it was in talks to sell off its consumer…

Investors Business Daily

What Does A Double Bottom Base Look Like? This Top Biotech Stock Formed A Great One

Bioverativ formed a perfect double bottom, a key chart pattern for growth stock hunters, and broke out ahead of its big 61% gain on news it's being bought by Sanofi.

The Conversation

Pharma company funding for patient advocacy groups needs to be transparent

Patient groups should be playing a central role in Canada’s health-care system, advocating for their members by promoting the visibility of their conditions, pushing for more rapid and accurate diagnoses and lobbying for the introduction and funding of new treatments and drugs that may help relieve their members’ symptoms and…

Investors Business Daily

Regeneron And Sanofi Snag Their $6 Billion-Potential COPD Approval For Dupixent

Regeneron stock rose Friday after the company won FDA approval for Dupixent in chronic obstructive pulmonary disease, or COPD.

The Conversation

Your gas stove might be making your asthma worse. Here’s what you can do about it

We may think of air pollution as an outdoor problem, made up of car exhaust and smog. But if the air inside our homes is polluted, this can also affect our health.

Fortune

Older adults 65+ should get flu shots earlier in the season. Here’s why they also need stronger vaccines

Two flu vaccines are FDA-approved exclusively for people 65 and older, who are at higher risk of severe infection.

Evening Standard

New RSV vaccine rolled out in London after virus hospitalised thousands in capital in a year

Officials say vaccination programme could prevent thousands of hospital admissions for babies

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

International Monetary Fund

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.